当前位置：首页 > 文献互助 > 互助详情

Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis.复制

用户7mX8GJfbOWSM 1小时前 11 10 求助中 帖子自动结束时间: 2026-03-07 10:34:14

1. 文件大小不能超过300M, 允许上传文档或压缩包等

2. 请确保上传文献的真实性、完整性，不得对原文做任何修改

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接: https://jddonline.com/articles/safety-and-efficacy-of-desonide-hydrogel-005-in-pediatric-subjects-with-atopic-dermatitis-S1545961607P0175X复制

其他信息:

AA Hebert, FE Cook-Bolden, S Basu…
Journal of drugs in …, 2007
europepmc.org
Low to mid potency corticosteroids remain a cornerstone of therapy for atopic dermatitis (AD). Since AD is most prevalent in the younger pediatric population and is chronic in nature, safety is of particular concern especially for children under 2 years of age. A novel desonide (0.05%) formulation was developed in a nonirritating and moisturizing aqueous gel (hydrogel) that is free of alcohol and surfactants. The safety and efficacy of this new class VI low potency topical steroid was substantiated in 2 phase III clinical trials in mild to …

上一篇：An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics

下一篇：Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins

互助时间线

2026-03-02 10:34:14 [发起求助]

最新发布的求助

In‐Situ Cross‐linked F‐ and P‐Containing Solid Polymer Electrolyte for Long‐Cycling and High‐Safety Lithium Metal Batteries with Various Cathode Materials 39分钟前
Cytoskeletal control of development and environmental adaptation in plants 50分钟前
Sulfite-Induced Release and Oxidation of Cr(III) in Reduced Chromite Ore Processing Residue under Visible Light: The Critical Role of Fe(IV) Intermediates 54分钟前
Ferrioxalate photocatalysis: A multitasking platform for reductive iron catalysis 57分钟前
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis 1小时前
One Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial DogmaOne Pivotal Trial, the New Default Option for FDA Approval — Ending the Two-Trial Dogma 1小时前
Vascular Transport of Alzheimer’s Amyloid β Peptides and Apolipoproteins 1小时前
Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis. 1小时前
An Industry Perspective on Key Considerations for the ICH S13 Guidance: Nonclinical Safety Evaluations of Oligonucleotide-Based Therapeutics 2小时前
Experimental Evidence of Underfill Voiding and Delamination during Board Level Assembly of Pb-free Solders 2小时前
Experimental Evidence of Underfill Voiding and Delamination during Board Level Assembly of Pb-free Solders 2小时前
World-first stem-cell therapy shows promise for treating spina bifida in the womb 2小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com